Zhiwen Xu

USPTO Granted Patents = 12 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 6.8

ph-index = 5

Forward Citations = 139(Granted Patents)

Location History:

Hong Kong, CN (2013 - 2021)
La Jolla, CA (US) (2022)
San Diego, CA (US) (2023)

Company Filing History:

Pangu Biopharma Limited

patents

1 out of 1

Paneu Biopharma Limited

patent

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11807687 - Therapeutic compositions comprising anti-NRP2 antibodies (2023-11-07),

2. 11505610 - Compositions and methods comprising anti-NRP2 antibodies (2022-11-22),

3. 11078299 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-08-03),

4. 10941214 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-03-09),

5. 10526419 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2020-01-07),

6. 10220080 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases (2019-03-05),

7. 10017582 - Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities (2018-07-10),

8. 9687533 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases (2017-06-27),

9. 9605265 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2017-03-28),

10. 8945541 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases (2015-02-03),

11. 8753638 - Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities (2014-06-17),

12. 8404242 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2013-03-26),

Title: The Innovative Journey of Zhiwen Xu

Introduction: Zhiwen Xu, a pioneering inventor hailing from Hong Kong, CN, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Zhiwen Xu's latest patents include cutting-edge technologies in the field of artificial intelligence and renewable energy, showcasing his commitment to pushing the boundaries of technological advancements.

Career Highlights: Throughout his illustrious career, Zhiwen Xu has been recognized for his innovative spirit and problem-solving abilities. His inventions have not only revolutionized industries but have also improved the quality of life for many around the globe.

Collaborations: Zhiwen Xu has collaborated with leading research institutions and tech companies to further develop and implement his inventions. His partnerships have been instrumental in bringing his ideas to life and making a tangible impact on society.

Conclusion: Zhiwen Xu's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a visionary inventor. His work continues to inspire future generations to think outside the box and strive for excellence in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.